# Filing Detail

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-24-015739
Filing Date
2024-04-24
Accepted
2024-04-23 20:47:34
Documents
62
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-ka.htm iXBRL | 10-K/A | 1515565
2 |  | ex32-1.htm | EX-32.1 | 8050
3 |  | form10-k_001.jpg | GRAPHIC | 22820
4 |  | form10-k_002.jpg | GRAPHIC | 12061
5 |  | form10-k_003.jpg | GRAPHIC | 20362
6 |  | form10-k_004.jpg | GRAPHIC | 17245
| Complete submission text file | 0001493152-24-015739.txt |  | 5524512

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | ptix-20231231.xsd | EX-101.SCH | 34612
8 | XBRL CALCULATION FILE | ptix-20231231_cal.xml | EX-101.CAL | 46708
9 | XBRL DEFINITION FILE | ptix-20231231_def.xml | EX-101.DEF | 180874
10 | XBRL LABEL FILE | ptix-20231231_lab.xml | EX-101.LAB | 355513
11 | XBRL PRESENTATION FILE | ptix-20231231_pre.xml | EX-101.PRE | 278875
66 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-ka_htm.xml | XML | 581723

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-12555 | Film No.: 24866512
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)